Roles and mechanisms of NRG1 in modulating the pathogenesis of NAFLD through ErbB3 signaling in hepatocytes (NRG1 modulates NAFLD through ErbB3 signaling)
Authors:
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Obesity Research & Clinical Practice
- Vol. 15 (2) , 145-151
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Zhejiang Province (LQ18H070006)
- National Natural Science Foundation of China (81800507)
- National Natural Science Foundation of China (ZRY2016B002)
This publication has 29 references indexed in Scilit:
- Maf1 Is a Novel Target of PTEN and PI3K Signaling That Negatively Regulates Oncogenesis and Lipid MetabolismPLOS Genetics, 2014
- The brown fat–enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesisNature Medicine, 2014
- Therapeutic potential of neuregulin-1 in cardiovascular diseaseDrug Discovery Today, 2013
- Roles for PI3K/AKT/PTEN Pathway in Cell Signaling of Nonalcoholic Fatty Liver DiseaseISRN Endocrinology, 2013
- Neuregulin 1-ErbB4-PI3K signaling in schizophrenia and phosphoinositide 3-kinase-p110δ inhibition as a potential therapeutic strategyProceedings of the National Academy of Sciences, 2012
- Phosphoinositide 3-kinase signaling is critical for ErbB3-driven breast cancer cell motility and metastasisOncogene, 2011
- Role for PPARγ in obesity‐induced hepatic steatosis as determined by hepatocyte‐ and macrophage‐specific conditional knockoutsThe FASEB Journal, 2011
- Pancreatic-derived factor promotes lipogenesis in the mouse liver: Role of the Forkhead box 1 signaling pathwayHepatology, 2011
- Neuregulin‐1 enhances survival of human astrocytic glioma cellsGlia, 2005
- Steatohepatitis: A tale of two “hits”?Gastroenterology, 1998